Medicare AdvantageDecember 16, 2024
Shortage of repackaged bevacizumab for ophthalmic use
On October 11, 2024, Pine Pharmaceuticals, the largest producer of repackaged bevacizumab (Avastin®), communicated that it would no longer be a supplier of repackaged, prefilled bevacizumab syringes.
Our preferred products include Avastin, Byooviz, Cimerli, Eylea, Eylea HD, Lucentis, and Vabysmo. To avoid access issues or treatment delays for members receiving this treatment, we encourage providers to reach out if necessary to our prior authorization department for an alternative antivascular endothelial growth factor drug for our members. All expedited requests for a Part B drug will have a determination made and the enrollee will be notified of the decision as expeditiously as the enrollee’s health condition requires, but no later than 24 hours after the request is received.
Anthem Blue Cross and Blue Shield is the trade name of Blue Cross Blue Shield of Wisconsin (BCBSWI), Compcare Health Services Insurance Corporation (Compcare), and Wisconsin Collaborative Insurance Company (WCIC). BCBSWI underwrites or administers PPO and indemnity policies and underwrites the out of network benefits in POS policies offered by Compcare or WCIC; Compcare underwrites or administers HMO or POS policies; WCIC underwrites or administers Well Priority HMO or POS policies. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
PCTS-1044-1, MULTI-ALL-CR-075366-24
PUBLICATIONS: January 2025 Provider Newsletter
To view this article online:
Or scan this QR code with your phone